Covered recipient · General Payments record
CAROLYN ANN NELSON
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2020–2024
$17,059.09
- Reported across 347 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,250.00 | 1 |
| Food and Beverage | $2,863.56 | 83 |
| Travel and Lodging | $1,355.49 | 1 |
| Long term medical supply or device loan | $259.92 | 2 |
| Education | $11.29 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CeQur Corporation | $5,389.16 | 2 |
| Tandem Diabetes Care, Inc. | $1,922.74 | 4 |
| Insulet Corporation | $401.43 | 8 |
| BETA BIONICS, INC. | $348.87 | 7 |
| Abbott Laboratories | $271.35 | 3 |
| Amgen Inc. | $269.22 | 8 |
| Corcept Therapeutics | $160.75 | 7 |
| Novo Nordisk AS | $142.89 | 13 |
| Lilly USA, LLC | $132.56 | 8 |
| Radius Health, Inc. | $112.59 | 1 |
| SANOFI-AVENTIS U.S. LLC | $85.58 | 3 |
| MannKind Corporation | $74.61 | 3 |
| DEXCOM, INC. | $72.26 | 4 |
| Xeris Pharmaceuticals, Inc. | $67.58 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $62.09 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $53.76 | 3 |
| Medtronic, Inc. | $41.31 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $35.94 | 1 |
| ABBVIE INC. | $31.65 | 2 |
| Ascensia Diabetes Care US Inc. | $24.22 | 1 |
| Astellas Pharma US Inc | $24.06 | 1 |
| Esperion Therapeutics, Inc. | $15.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (88)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.